Revision of fees will be prescribed on all Licensing, Registration and other Certification
July 31, 2016
Meanwhile in Philippines, Food and Drug Administration Philippines (FDA) has come out with a Draft for New Schedule of Fees and Charges of FDA on Licensing, Registration and other Certification. The rationale for the revision of fees is because of the income retention and withdrawal of subsidy by the Philippines government to FDA. Due to this change, fees and charges will be the only source of funding support for operations and capital expenditures thus making it a need to implement the adjustments.